• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

DNA sequencing of MRSA used to stop outbreak

Shiloh

Editor, Senior Moderator
Source: http://www.bbc.co.uk/news/health-20314024


13 November 2012 Last updated at 20:03 ET

DNA sequencing of MRSA used to stop outbreak
By James Gallagher Health and science reporter, BBC News

An outbreak of the hospital superbug MRSA has been brought to an end by UK doctors cracking the bacterium's genetic code.

It led to them finding one member of staff at Rosie Hospital, in Cambridge, who may have unwittingly carried and spread the infection.

They say it is the first time rapid genetic testing has been used to track and then stop an outbreak.

One expert said this would soon become "standard practice" in hospitals...
 
Re: DNA sequencing of MRSA used to stop outbreak

[Source: The Lancet Infectious Diseases, full page: (LINK). Abstract, edited.]

The Lancet Infectious Diseases, Early Online Publication, 14 November 2012

doi:10.1016/S1473-3099(12)70268-2

This article can be found in the following collections: Genetics & Genomics; Infectious Diseases (Anti-infective therapy, Healthcare-associated infections, Paediatric infections, Infectious diseases-other); Paediatrics (Paediatric infections)

Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study

Original Text


Simon R Harris PhD a *, Edward JP Cartwright MBBS b d *, M Est?e T?r?k FRCP b d e, Matthew TG Holden PhD a, Nicholas M Brown MD d e, Amanda L Ogilvy-Stuart FRCP e, Matthew J Ellington DPhil d, Michael A Quail PhD a, Stephen D Bentley PhD a, Prof Julian Parkhill PhD a ?, Prof Sharon J Peacock FRCP a b c d e ?



Summary

Background

The emergence of meticillin-resistant Staphylococcus aureus (MRSA) that can persist in the community and replace existing hospital-adapted lineages of MRSA means that it is necessary to understand transmission dynamics in terms of hospitals and the community as one entity. We assessed the use of whole-genome sequencing to enhance detection of MRSA transmission between these settings.


Methods

We studied a putative MRSA outbreak on a special care baby unit (SCBU) at a National Health Service Foundation Trust in Cambridge, UK. We used whole-genome sequencing to validate and expand findings from an infection-control team who assessed the outbreak through conventional analysis of epidemiological data and antibiogram profiles. We sequenced isolates from all colonised patients in the SCBU, and sequenced MRSA isolates from patients in the hospital or community with the same antibiotic susceptibility profile as the outbreak strain.


Findings

The hospital infection-control team identified 12 infants colonised with MRSA in a 6 month period in 2011, who were suspected of being linked, but a persistent outbreak could not be confirmed with conventional methods. With whole-genome sequencing, we identified 26 related cases of MRSA carriage, and showed transmission occurred within the SCBU, between mothers on a postnatal ward, and in the community. The outbreak MRSA type was a new sequence type (ST) 2371, which is closely related to ST22, but contains genes encoding Panton-Valentine leucocidin. Whole-genome sequencing data were used to propose and confirm that MRSA carriage by a staff member had allowed the outbreak to persist during periods without known infection on the SCBU and after a deep clean.


Interpretation

Whole-genome sequencing holds great promise for rapid, accurate, and comprehensive identification of bacterial transmission pathways in hospital and community settings, with concomitant reductions in infections, morbidity, and costs.


Funding

UK Clinical Research Collaboration Translational Infection Research Initiative, Wellcome Trust, Health Protection Agency, and the National Institute for Health Research Cambridge Biomedical Research Centre.

a Wellcome Trust Sanger Institute, Cambridge, UK; b Department of Medicine, University of Cambridge, Cambridge, UK; c Department of Pathology, University of Cambridge, Cambridge, UK; d Cambridge Microbiology and Public Health Laboratory, Cambridge, UK; e Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK

Correspondence to: Prof Sharon J Peacock, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK

* Joint first authors

? Contributed equally
-
--------
 
Back
Top Bottom